| Literature DB >> 26908984 |
Jinhee Jang1, Seung Eun Jung1, Woo Kyoung Jeong2, Yeon Soo Lim3, Joon-Il Choi1, Michael Yong Park1, Yongsoo Kim4, Seung-Koo Lee5, Jae-Joon Chung6, Hong Eo2, Hwan Seok Yong7, Sung Su Hwang8.
Abstract
Emerging concerns regarding the hazard from medical radiation including CT examinations has been suggested. The purpose of this study was to observe the longitudinal changes of CT radiation doses of various CT protocols and to estimate the long-term efforts of supervising radiologists to reduce medical radiation. Radiation dose data from 11 representative CT protocols were collected from 12 hospitals. Attending radiologists had collected CT radiation dose data in two time points, 2007 and 2010. They collected the volume CT dose index (CTDIvol) of each phase, number of phases, dose length product (DLP) of each phase, and types of scanned CT machines. From the collected data, total DLP and effective dose (ED) were calculated. CTDIvol, total DLP, and ED of 2007 and 2010 were compared according to CT protocols, CT machine type, and hospital. During the three years, CTDIvol had significantly decreased, except for dynamic CT of the liver. Total DLP and ED were significantly decreased in all 11 protocols. The decrement was more evident in newer CT scanners. However, there was substantial variability of changes of ED during the three years according to hospitals. Although there was variability according to protocols, machines, and hospital, CT radiation doses were decreased during the 3 years. This study showed the effects of decreased CT radiation dose by efforts of radiologists and medical society.Entities:
Keywords: Longitudinal Studies; Multidetector Computed Tomography; Radiation Dose; Radiology
Mesh:
Year: 2016 PMID: 26908984 PMCID: PMC4756338 DOI: 10.3346/jkms.2016.31.S1.S24
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Hardware specification of studied CT scanners
| Machine type | 2007 | 2010 | Group 1 |
|---|---|---|---|
| Detector row < 64 (type A) | 11 | 13 | 7 |
| Detector row ≥ 64 (type B) | 9 | 15 | 7 |
| Dual source (type C) | 0 | 4 | 0 |
| Total number | 20 | 32 | 14 |
Comparison of effective doses between 2007 and 2010: total data and group 1 data
| Protocols | Total | Group 1 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. | ED, mSv | No. | ED, mSv | |||||||
| yr | 2007 | 2010 | 2007 | 2010 | 2007 | 2010 | 2007 | 2010 | ||
| CTliver | 130 | 289 | 22.8 ± 9.1 | 19.9 ± 8.0 | 0.002 | 120 | 119 | 22.8 ± 9.1 | 19.7 ± 7.4 | 0.001 |
| CTabdomen | 139 | 299 | 16.7 ± 8.2 | 9.8 ± 6.1 | < 0.001 | 129 | 126 | 16.7 ± 8.2 | 10.1 ± 7.1 | < 0.001 |
| CTU | 58 | 196 | 30.3 ± 11 | 20.9 ± 8.7 | < 0.001 | 48 | 50 | 30.3 ± 11.0 | 19.1 ± 9.5 | < 0.001 |
| CTstone | 119 | 270 | 8.8 ± 3.2 | 6.7 ± 3.4 | < 0.001 | 116 | 120 | 8.8 ± 3.2 | 6.7 ± 3.9 | < 0.001 |
| CTchest | 140 | 283 | 8.8 ± 3.6 | 7.2 ± 3.2 | < 0.001 | 130 | 129 | 8.8 ± 3.6 | 7.3 ± 3.1 | < 0.001 |
| HRCT | 90 | 181 | 12.0 ± 11.7 | 4.9 ± 3.1 | < 0.001 | 80 | 80 | 12.0 ± 11.7 | 5.9 ± 3.4 | < 0.001 |
| LDCT | 110 | 226 | 1.8 ± 1.6 | 1.1 ± 0.5 | < 0.001 | 100 | 100 | 1.8 ± 1.6 | 1.2 ± 0.4 | < 0.001 |
| CTAcoronary | 60 | 110 | 17.2 ± 7.7 | 10.9 ± 6.1 | < 0.001 | 40 | 40 | 17.2 ± 7.7 | 9.8 ± 6.6 | < 0.001 |
| CTbrain | 115 | 237 | 2.2 ± 0.8 | 1.8 ± 0.6 | < 0.001 | 105 | 106 | 2.2 ± 0.8 | 2.0 ± 0.4 | 0.027 |
| CTAbrain | 80 | 180 | 4.3 ± 2.5 | 3.6 ± 1.7 | 0.028 | 70 | 68 | 4.3 ± 2.5 | 4.1 ± 1.6 | 0.499 |
| CTPbrain | 60 | 120 | 8.5 ± 5.5 | 6.0 ± 3 | 0.001 | 58 | 70 | 8.5 ± 5.5 | 6.4 ± 2.8 | 0.006 |
| Total | 1101 | 2391 | 996 | 1008 | ||||||
CTliver, dynamic-contrast-enhanced CT of the liver; CTabdomen, routine abdomen CT; CTU, CT urography; CTstone, non-enhanced CT for urolithiasis; CTchest, routine chest CT; HRCT, high resolution chest CT; LDCT, low dose chest CT; CTAcoronary, coronary CT angiography; CTbrain, non-enhanced brain CT; CTAbrain, CT angiography of the brain: CTPbrain, CT perfusion study of the brain.
Fig. 1Mean effective doses according to 11 CT protocols. (A) Total data comparison between 2007 and 2010. (B) Comparison from the data of same CT scanners from 2007 and 2010 (group 1).
Comparison of CTDIvol and total DLP between 2007 and 2010
| Protocols | Total | Group 1 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDTIvol, mGy | Total DLP, mGy × cm | CDTIvol, mGy | Total DLP, mGy × cm | |||||||||
| yr | yr | yr | yr | |||||||||
| 2007 | 2010 | 2007 | 2010 | 2007 | 2010 | 2007 | 2010 | |||||
| CTliver | 11.5 ± 4.2 | 11.2 ± 4.3 | 0.459 | 1511.5 ± 607.9 | 1288.3 ± 485.6 | < 0.001 | 11.5 ± 4.2 | 10.1 ± 3.8 | 0.002 | 1511.5 ± 607.9 | 1298.9 ± 490.6 | 0.001 |
| CTabdomen | 11.2 ± 3.6 | 9.9 ± 3.3 | < 0.001 | 1101.4 ± 531.8 | 649.1 ± 403.1 | < 0.001 | 11.2 ± 3.6 | 9.3 ± 2.8 | < 0.001 | 1101.4 ± 531.8 | 670.9 ± 469.1 | < 0.001 |
| CTU | 12.5 ± 3.8 | 9.2 ± 3.5 | < 0.001 | 2008.7 ± 730.4 | 1389.1 ± 579.1 | < 0.001 | 12.5 ± 3.8 | 8.2 ± 3.5 | < 0.001 | 2008.7 ± 730.4 | 1263.8 ± 632.7 | < 0.001 |
| CTstone | 11.2 ± 3.7 | 8.7 ± 4.2 | < 0.001 | 583.4 ± 211.0 | 446.7 ± 226.7 | < 0.001 | 11.2 ± 3.7 | 8.2 ± 4.6 | < 0.001 | 583.4 ± 211.0 | 444.5 ± 257.8 | < 0.001 |
| CTchest | 10.9 ± 3.2 | 8.3 ± 3.6 | < 0.001 | 625.9 ± 252.0 | 511.4 ± 225.2 | < 0.001 | 10.9 ± 3.2 | 8.3 ± 2.8 | < 0.001 | 625.9 ± 252.0 | 520.1 ± 219.3 | < 0.001 |
| HRCT | 14.4 ± 10.9 | 7.9 ± 2.7 | < 0.001 | 854.3 ± 838.2 | 349.6 ± 218.6 | < 0.001 | 14.4 ± 10.9 | 8.6 ± 2.6 | < 0.001 | 854.3 ± 838.2 | 420.3 ± 245.8 | < 0.001 |
| LDCT | 3.3 ± 3.0 | 2.1 ± 0.8 | < 0.001 | 124.8 ± 112.0 | 78.5 ± 32.1 | < 0.001 | 3.3 ± 3.0 | 2.3 ± 0.8 | < 0.001 | 124.8 ± 112.0 | 85.0 ± 31.8 | < 0.001 |
| CTAcoronary | 62.1 ± 25.7 | 38.4 ± 22.4 | < 0.001 | 1181.4 ± 527.1 | 675.7 ± 375.9 | < 0.001 | 62.1 ± 25.7 | 36.3 ± 23.5 | < 0.001 | 1181.4 ± 527.1 | 650.3 ± 391.3 | < 0.001 |
| CTbrain | 64.7 ± 21.0 | 49.5 ± 12.2 | < 0.001 | 1053.0 ± 397.4 | 853.5 ± 267.0 | < 0.001 | 64.7 ± 21.0 | 54.6 ± 8.8 | < 0.001 | 1053.0 ± 397.4 | 963.0 ± 211.4 | 0.027 |
| CTAbrain | 41.5 ± 14.0 | 33.0 ± 12.3 | < 0.001 | 2006.0 ± 1182.1 | 1703.1 ± 790.9 | 0.029 | 41.5 ± 14.01 | 35.4 ± 11.0 | < 0.001 | 2006.0 ± 1182.1 | 1909.6 ± 752.8 | 0.489 |
| CTPbrain | 667.2 ± 359.9 | 396.8 ± 215.6 | < 0.001 | 4043.8 ± 2620.9 | 2836.0 ± 1427.7 | 0.001 | 667.2 ± 359.9 | 418.4 ± 212.3 | < 0.001 | 4043.8 ± 2620.9 | 3036.1±1319.4 | 0.007 |
CTliver, dynamic-contrast-enhanced CT of the liver; CTabdomen, routine abdomen CT; CTU, CT urography; CTstone, non-enhanced CT for urolithiasis; CTchest, routine chest CT; HRCT, high resolution chest CT; LDCT, low dose chest CT; CTAcoronary, coronary CT angiography; CTbrain, non-enhanced brain CT; CTAbrain, CT angiography of the brain: CTPbrain, CT perfusion study of the brain.
Fig. 2Percentage changes of the volume CT dose index (CTDIvol) and total dose-length product (DLP) of 11 CT protocols. (A) Total data comparison between 2007 and 2010. (B) Comparison from data of same CT scanners from 2007 and 2010 (group 1). Note the discrepancies between reduction of CTDIvol and total DLP in CTliver, CTabdomen, and HRCT. A similar trend was observed in group 1.
Comparison of effective doses between 2007 and 2010: type A and B CTs
| Protocols | Type A CT | Type B CT | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. | ED, mSv | No. | ED, mSv | |||||||
| yr | 2007 | 2010 | 2007 | 2010 | 2007 | 2010 | 2007 | 2010 | ||
| CTliver | 60 | 60 | 2.0 ± 6.7 | 17.8 ± 6.4 | 0.047 | 60 | 59 | 26.1 ± 10.5 | 21.2 ± 8.4 | 0.003 |
| CTabdomen | 60 | 58 | 14.8 ± 5.5 | 9.3 ± 4.0 | <0.001 | 69 | 68 | 18.7 ± 9.9 | 10.6 ± 8.6 | <0.001 |
| CTU | 19 | 20 | 24.4 ± 10.9 | 21.6 ± 8.1 | 0.340 | 29 | 30 | 33.2 ± 9.9 | 17.9 ± 9.4 | <0.001 |
| CTstone | 46 | 50 | 7.3 ± 2.6 | 7.1 ± 2.7 | 0.680 | 70 | 70 | 9.8 ± 3.2 | 6.4 ± 4.6 | <0.001 |
| CTchest | 60 | 60 | 7.9 ± 2.4 | 7.8 ± 2.4 | 0.775 | 70 | 69 | 9.7 ± 4.3 | 7.2 ± 3.6 | <0.001 |
| HRCT | 40 | 40 | 5.4 ± 3.2 | 5.1 ± 3.4 | 0.671 | 40 | 40 | 17.2 ± 13.4 | 6.8 ± 3.5 | <0.001 |
| LDCT | 50 | 50 | 1.3 ± 0.5 | 1.3 ± 0.5 | 0.972 | 50 | 50 | 2.1 ± 2.1 | 1.1 ± 0.4 | <0.001 |
| CTAcoronary | 0 | 0 | 40 | 40 | 17.2 ± 7.7 | 11.3 ± 6.7 | <0.001 | |||
| CTbrain | 56 | 57 | 2.0 ± 0.4 | 2.0 ± 0.5 | 0.608 | 49 | 49 | 2.6 ± 1.1 | 2.1 ± 0.5 | 0.003 |
| CTAbrain | 20 | 19 | 2.3 ± 2.0 | 4.2 ± 2.2 | 0.001 | 50 | 49 | 5.3 ± 2.1 | 4.1 ± 1.4 | <0.001 |
| CTPbrain | 20 | 20 | 4.7 ± 1.7 | 3.8 ± 1.8 | 0.113 | 38 | 50 | 10.7 ± 5.7 | 7.3 ± 2.6 | <0.001 |
| Total | 431 | 434 | 565 | 574 | ||||||
CTliver, dynamic-contrast-enhanced CT of the liver; CTabdomen, routine abdomen CT; CTU, CT urography; CTstone, non-enhanced CT for urolithiasis; CTchest, routine chest CT; HRCT, high resolution chest CT; LDCT, low dose chest CT; CTAcoronary, coronary CT angiography; CTbrain, non-enhanced brain CT; CTAbrain, CT angiography of the brain: CTPbrain, CT perfusion study of the brain.
Fig. 3Changes of mean effective doses of 8 hospitals in group 1. Note the variability of EDs at 2007 and changes during 3 years according to the protocols.